Nadir Mahmood returns to Nkarta a year after leaving; BeiGene picks longtime Merck exec for CFO post
For new Nkarta president Nadir Mahmood, home is where the heart is.
The five-year veteran of the NK cell therapy biotech is returning after a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
